Author pages are created from data sourced from our academic publisher partnerships and public sources.
Autoimmune Renal Disease Is Exacerbated by S1P-Receptor-1-Dependent Intestinal Th17 Cell Migration to the Kidney
Summary Th17 cells are most abundant in the gut, where their presence depends on the intestinal microbiota. Here, we examined whether intestinal Th17 cells contribute to extra-intestinal Th17… Expand
A Mechanism for Cancer-Associated Membranous Nephropathy.
- Elion Hoxha, T. Wiech, +9 authors Rolf A.K. Stahl
- The New England journal of medicine
- 18 May 2016
The cause of paraneoplastic membranous nephropathy is unclear. In the current case, new expression of THSD7A in a gallbladder carcinoma and the development of membranous nephropathy may indicate a… Expand
Potential Role for Urine Polymerase Chain Reaction in the Diagnosis of Whipple’s Disease
- A. Moter, Matthias Janneck, +14 authors T. Wiech
- Clinical infectious diseases : an official…
- 22 October 2018
Abstract Background Whipple’s disease (WD) is a rare infection with Tropheryma whipplei that is fatal if untreated. Diagnosis is challenging and currently based on invasive sampling. In a case of WD… Expand
Implementation of a Clinical Reasoning Course in the Internal Medicine trimester of the final year of undergraduate medical training and its effect on students' case presentation and differential…
- S. Harendza, I. Krenz, Andreas Klinge, Ulrike Wendt, Matthias Janneck
- Psychology, Medicine
- GMS journal for medical education
- 15 November 2017
Background: Clinical reasoning, comprising the processes of clinical thinking, which form the basis of medical decisions, constitutes a central competence in the clinical routine on which diagnostic… Expand
Severe Acute Kidney Injury Due to Nivolumab/Ipilimumab-induced Granulomatosis and Fibrinoid Vascular Necrosis.
- F. Person, Tuhama Chahoud-Schriefer, Wilfrid Fehrle, Matthias Janneck, T. Huber, T. Wiech
- Journal of immunotherapy
Immune-checkpoint inhibitors have revolutionized the treatment of cancers in recent years. Four drugs have obtained FDA approval in a variety of cancer types. Immune-related adverse events are common… Expand